A technological process with a legal-ethical core

Dec 21, 2023 | Legacy News

From October 23-27 2023, Horizon Europe 2024 – the European Research Promotion Agency’s (APRE) annual event – took place with 5 days of information meetings on the themes and calls of the Framework Program for Research and Innovation.

It was a relay of information sessions, insights, and interactions to accompany Italian researchers and innovators “inside” all aspects and opportunities of the Framework Program for the year 2024, with the goal of activating as a national system to participate and win. Together with APRE experts, European Commission officials and national representatives in their respective configurations interacted and presented their point of view and experience.

During the second day of the event, Professor Johanna Blom, IHI-FACILITATE Coordinator, was invited to present the key themes of the project, which originated from a public-private partnership with EFPIA and was coordinated for the first time by Italy.

First, Blom recalled the purpose of FACILITATE, a large consortium of 29 European and non-European partners with diverse expertise implemented to create a prototype process for returning individual clinical trial data to participants and for their secondary reuse. Emphasizing how current data protection legislation – the GDPR – represents a limitation to research competitiveness in Europe, Blom referred to FACILITATE as a new process that could be implementable by industry starting with patient needs.

The consideration of how to reconcile Big Data with current laws led FACILITATE researchers to seek the answer to a series of questions: could good faith GDPR legal safeguards make de facto Europe non-competitive? On what basis to realize secondary use of data? Is consent truly informed in Italy? What can we do that is truly innovative?

FACILITATE is trying to realize the creation of an integrated ethical-legal common core – which is currently absent – based on ethical principles that can be expressed maximally within minimal legal constraints. This ethical-legal core fuels a process which is based on a solid technology system, supported by the continuous input of all stakeholders.

“To overcome the status quo,” Blom concludes “We need to recreate the basis for trust between researchers and patients, find new ethical ways of participation that reconsider the right to opt in and opt out, think about new forms of consent, consider a new way of accessing personal data, because access to good quality data remains impossible with the current limitations.”



For secondary use, trust is the key word

In the last two months, FACILITATE researchers of Workpackage 3 have organized and managed three different consultations with patients and experts about granularity of choice in Secondary Use of Data in the clinical trial context.The first consultation – entitled...

Demystifying Individual Participant Data Return

On 17 October, 2023, Johanna Blom, Coordinator of FACILITATE, Véronique Poinsot, Project Leader of FACILITATE and Swapna Pothula, member of the TransCelerate initiative, participated at Scope EU Congress in Barcelona, in a panel entitled “Demystifying Individual...

Expert patients meet FACILITATE

On 15 October 2023, the Accademia del Paziente Esperto EUPATI (AdPEE) held an information event dedicated to the European FACILITATE project at the Rome Scout Center in Rome. Sabrina Grigolo, member of the board of AdPEE, together with some EUPATI Patient Experts -...

Individual data return is now reality

in the USA, participants to clinical trials can now have consistent and reliable access to their individual data through a Pfizer innovative initiative.Pfizer has made a commitment to return individual data to its clinical trials participants through the Participant...


Do you want to receive our updates, access information on our activities and events and be in contact with our project?

Latest News

Upcoming Events